ADHD & ADD Program | Today Telemedicine

ADHD/ADD Program

Please note: this program is limited to non-stimulant ADHD treatment options only. Stimulant medications such as Adderall, Vyvanse, Concerta, and Ritalin are not prescribed through this program.

What is ADHD?

Attention-deficit/hyperactivity disorder, or ADHD, is a condition that can affect attention, focus, organization, impulsivity, and activity level. Symptoms can look different from person to person and may affect work, school, daily routines, and overall functioning.

At Today Telemedicine, we evaluate ADHD symptoms and offer support through a structured telemedicine process that may include history review, symptom assessment, and QbCheck when clinically appropriate.

ADHD Evaluation and Non-Stimulant Treatment Options

We offer ADHD evaluations through a structured telemedicine process that may include history review, symptom assessment, and QbCheck when clinically appropriate.

Our ADHD program focuses on evaluation, education, and non-stimulant treatment options only. We do not prescribe stimulant medications, including Adderall, Vyvanse, Concerta, Ritalin, or similar controlled ADHD medications.

When medication is appropriate, treatment recommendations may include FDA-approved non-stimulant options such as atomoxetine, guanfacine, clonidine, and viloxazine. These recommendations are based on each patient’s symptoms, history, and clinical needs.

QbCheck

Remote ADHD testing that can be completed when recommended by your provider
Provides additional objective data to support the evaluation process
Helps assess attention and activity-related patterns
Can be used as part of diagnosis and treatment planning
Convenient telemedicine-friendly option

FDA-Approved Non-Stimulant Medication Options

Atomoxetine
Guanfacine
Clonidine
Viloxazine
Treatment recommendations are based on each patient’s symptoms, history, and clinical needs

How Our ADHD Program Can Help

Our program is designed to help patients better understand ADHD symptoms and explore appropriate next steps for care.

This may include support with:

Attention and focus difficulties
Disorganization and trouble following through
Restlessness or impulsivity
Feeling overwhelmed by daily responsibilities

Because ADHD symptoms can sometimes overlap with or exist alongside concerns such as anxiety, depression, sleep issues, or stress, our evaluation process considers the full picture when making treatment recommendations.

How the Program Works

A simple telemedicine process from evaluation to follow-up.

1. Initial Evaluation. Start with an online appointment to review symptoms, history, and clinical concerns.

2. Assessment and Treatment Planning. When appropriate, QbCheck may be used as part of the evaluation. If treatment is recommended, we focus on non-stimulant options only.

3. Follow-Up Care. Continue with telemedicine follow-up visits for monitoring, support, and treatment adjustments as clinically appropriate.

Please note: this program does not prescribe stimulant medications, including Adderall, Vyvanse, Concerta, or Ritalin. When clinically appropriate, treatment recommendations may include FDA-approved non-stimulant options such as atomoxetine, guanfacine, clonidine, or viloxazine.

Download Forms

To begin your ADHD/ADD care, please download and complete the attached forms as well:

Telemedicine Physical Exam Form (Required)

This form is important to begin your treatment because it helps us understand your medical history and what you might need.

Download Telemedicine Referral Form

Release of Information Form (Optional)

If you have a previous ADHD/ADD diagnosis, then please use this form to consent to transfer your health information to us. It's a great way to make sure we have all the details to provide the best care for you.

Download Release of Information Form

Affordable ADHD Care with Clear Options

Self-Pay Options

Initial Evaluation: $350
Follow-Up Visit: $175
QbCheck: $199

We provide transparent self-pay pricing for patients seeking ADHD evaluation and non-stimulant treatment options.

Insurance Coverage

Many insurance plans may cover ADHD evaluation and follow-up care. Coverage varies by plan, and our team can help review available options.

FDA-Approved Non-Stimulant ADHD Treatment Options

Our ADHD program focuses on evaluation, education, and FDA-approved non-stimulant treatment options only.

When clinically appropriate, treatment recommendations may include atomoxetine, guanfacine, clonidine, or viloxazine.

We do not prescribe stimulant medications such as Adderall, Vyvanse, Concerta, Ritalin, or similar controlled ADHD medications.

FAQs

Is ADHD the same as autism?

No. ADHD and autism are different conditions with different diagnostic criteria, although some symptoms can overlap and some individuals may have both.

How is ADHD evaluated?

ADHD evaluation may include a clinical interview, symptom review, history, and QbCheck when clinically appropriate. Treatment recommendations are based on the full clinical picture.

What treatment options do you offer for ADHD?

We offer evaluation, follow-up care, and non-stimulant treatment options only. When clinically appropriate, recommendations may include atomoxetine, guanfacine, clonidine, or viloxazine.

Do you prescribe Adderall or other stimulant medications?

No. This program does not prescribe stimulant medications, including Adderall, Vyvanse, Concerta, Ritalin, or similar controlled ADHD medications.

We’d love to hear from you. Request an appointment through our convenient online form or contact our team today to get started.